SaMD(Software as a Medical Device) 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global software as a medical device (SaMD) market size is expected to reach USD 78.81 Billion in 2034 from USD 4.39 Billion in 2025, growing at a CAGR of 37.83% during 2026-2034.This market is developing as software increasingly performs medical functions independently of dedicated hardware. Software as a Medical Device includes applications designed for purposes such as medical image analysis, disease detection, clinical decision support, patient monitoring, and treatment management. Growing adoption of digital healthcare, artificial intelligence, and connected medical technologies is encouraging the development of software-based medical solutions. Healthcare providers and technology companies are exploring these tools to support clinical decisions, improve diagnostic workflows, and expand access to specialized capabilities. Increasing availability of digital health data is also creating opportunities for software products designed for specific medical needs.

The growth of this market is driven by advances in artificial intelligence, increasing demand for diagnostic support, and the expansion of remote healthcare services. SaMD solutions can analyze medical images, interpret selected health data, and assist healthcare professionals with clinical assessments when appropriately validated. Their ability to operate across compatible digital platforms can support flexible deployment in hospitals, clinics, and other care settings. Pharmaceutical companies and medical technology developers are also exploring software-based tools for clinical research and patient management. However, regulatory classification, clinical validation, cybersecurity, patient data privacy, and integration with existing healthcare systems remain important challenges for developers.

The future prospects of this market are expected to be shaped by advances in AI algorithms, digital health infrastructure, and personalized medical technologies. Improved software capabilities may support more sophisticated image analysis, risk assessment, and clinical workflow automation. Cloud computing and connected healthcare platforms could facilitate software deployment and updates, subject to appropriate security and regulatory controls. Greater collaboration among software developers, healthcare providers, and medical researchers may help establish effective clinical applications. Future growth will depend on demonstrated safety and effectiveness, regulatory compliance, transparency, data protection, and the ability to integrate software into healthcare workflows while maintaining professional oversight and patient trust.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Deployment

• Cloud-based
• On-Premise

By End-user

• Hospitals and Clinics
• Ambulatory / Specialist Centers
• Home Care Settings

By Application

• Screening and Early Detection
• Chronic Condition Management
• Digital Therapeutics
• Clinical Decision Support

By IMDRF Risk Class

• Category I
• Category II
• Category III
• Category IV

COMPANIES PROFILED

• MindMaze, Siemens Healthineers, Biofourmis, Digital Diagnostics Inc., Silicon and Software Systems Ltd., BrightInsight, Arterys, Medtronic plc, iSchemaView Inc., Apple, GE Healthcare, Roche, Johnson and Johnson, Closed Loop Medicine, Amazon AWS Health, Google (Verily), Microsoft Cloud for Healthcare, AliveCor, Viz.ai, Pear Therapeutics

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET: BY DEPLOYMENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Deployment
• 4.2. Cloud-based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. On-Premise Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET: BY END-USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-user
• 5.2. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Ambulatory / Specialist Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Screening and Early Detection Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Chronic Condition Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Digital Therapeutics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Clinical Decision Support Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET: BY IMDRF RISK CLASS 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Imdrf Risk Class
• 7.2. Category I Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Category II Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Category III Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Category IV Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET: BY REGION 2022-2034 (USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Deployment
  • 8.2.2 By End-user
  • 8.2.3 By Application
  • 8.2.4 By Imdrf Risk Class
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Deployment
  • 8.3.2 By End-user
  • 8.3.3 By Application
  • 8.3.4 By Imdrf Risk Class
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Spain
  • 8.3.10 Russia
  • 8.3.11 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Deployment
  • 8.4.2 By End-user
  • 8.4.3 By Application
  • 8.4.4 By Imdrf Risk Class
  • 8.4.5 China
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 India
  • 8.4.9 Australia
  • 8.4.10 South East Asia
  • 8.4.11 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Deployment
  • 8.5.2 By End-user
  • 8.5.3 By Application
  • 8.5.4 By Imdrf Risk Class
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Deployment
  • 8.6.2 By End-user
  • 8.6.3 By Application
  • 8.6.4 By Imdrf Risk Class
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 MindMaze
  • 10.2.2 Siemens Healthineers
  • 10.2.3 Biofourmis
  • 10.2.4 Digital Diagnostics Inc
  • 10.2.5 Silicon And Software Systems Ltd
  • 10.2.6 BrightInsight
  • 10.2.7 Arterys
  • 10.2.8 Medtronic Plc
  • 10.2.9 ISchemaView Inc
  • 10.2.10 Apple
  • 10.2.11 GE Healthcare
  • 10.2.12 Roche
  • 10.2.13 Johnson And Johnson
  • 10.2.14 Closed Loop Medicine
  • 10.2.15 Amazon AWS Health
  • 10.2.16 Google (Verily)
  • 10.2.17 Microsoft Cloud For Healthcare
  • 10.2.18 AliveCor
  • 10.2.19 Viz.ai
  • 10.2.20 Pear Therapeutics